Results 151 to 160 of about 29,994,236 (203)

O3 Heme-arginate as a latency-reversing agent for HIV-1 cure

open access: yesJournal of Virus Eradication, 2017
Michaela Madlenakova   +6 more
openaire   +2 more sources

Rapamycin-mediated mTOR inhibition uncouples HIV-1 latency reversal from cytokine-associated toxicity. [PDF]

open access: yesJ Clin Invest, 2017
Martin AR   +5 more
europepmc   +1 more source

Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator Systems. [PDF]

open access: yesPLoS One, 2016
Bialek JK   +7 more
europepmc   +1 more source

<i>Euphorbia kansui</i> for latent virus reactivation in people living with HIV on suppressive antiretroviral therapy: A phase 1b/2a clinical trial. [PDF]

open access: yesJ Virus Erad
Xun J   +23 more
europepmc   +1 more source

Selection of effective LRAs using a newly designed <i>in vitro</i> HIV latency reactivation protocol: toward future application in HIV samples. [PDF]

open access: yesMicrobiol Spectr
Neri A   +14 more
europepmc   +1 more source

Kinetics of HIV-1 Latency Reversal Quantified on the Single-Cell Level Using a Novel Flow-Based Technique. [PDF]

open access: yesJ Virol, 2016
Martrus G   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy